WFDC2 and COVID-19: As we stated above, there was a significant difference in baseline HE4 serum level between COVID-19 survivors and non-survivors, and based on the ROC-AUC curve analysis, this biomarker efficiently estimated the outcome of this disease at the cut-off value of 331.7 pmol/L (see Fig. 3B).